This month, we had the honor of welcoming Lehendakari Imanol Pradales and key members of his government team to our facilities; Mikel Jauregi, Minister of Industry, Energy Transition and Sustainability; Juan Ignacio Pérez Iglesias, Minister of Science, University, and Innovation; and Jaione Ganzarain, Deputy Minister of Technology, Innovation, and Digital Transformation.
During their visit, we had the opportunity to share Viralgen’s mission of bringing advanced treatments to those who need them most, to showcase the science that takes place in our laboratories and give insights on AAVs (Adeno-Associated Virus vectors) manufacturing process, critical to gene therapies.
We are deeply grateful to have hosted these important visitors/ stakeholders and appreciate the continuous support critical for developing innovative therapies in the Basque country. This visit strengthens our commitment to health and innovation, as we work together to advance progress in the field of gene therapies.
News
September 26, 2024
Visit of Lehendakari Imanol Pradales and his team to Viralgen facilities: A step forward in advancing gene therapies
Explore more
Insights
Harnessing AI for Faster and More Efficient Development & Manufacturing of Life-Changing Gene Therapies
Authors: María Iglesias, Head of Digital & IT Jens Keune, Data Science & Digital Product Manager Abstract As the biopharmaceutical landscape evolves, the integration of Artificial Intelligence (AI) into gene therapy manufacturing is increasingly...
READ MORE
July 28, 2025

Resources
Webinar: Outsourced Pharma Capacity Update July 2025 - Fill/Finish
“May you live in interesting times.” Viralgen Chief Commercial Officer Andy Holt invokes that apocryphal “half-blessing, half-curse” as he opens his recent appearance on Outsourced Pharma Capacity Update. Andy identifies some of the key dynamics...
READ MORE
July 17, 2025
Resources
Webinar: Exploring key regulatory considerations to ensure patient safety in the gene therapy space
In July, a panel of expert speakers—Christine Lebec (Sensorion), Leigh Shaw (SpliceBio), Nathalie Clement (Siren Biotechnology), and María Orío (Viralgen)—came together to explore the evolving regulatory landscape in the cell and gene therapy (CGT)...
READ MORE
July 09, 2025